Today’s paths for translating research into impact are suboptimal: academia tends to be risk‑averse and rewards publications and grants over translational work; industry often focuses on short‑term incentives; and startups usually lack the capital, expertise, and complex infrastructure needed for long‑term scientific progress
You are viewing a single comment's thread from: